
Brenda Libby Coleman
Examiner (ID: 16325)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 2611, 1624, 1611 |
| Total Applications | 3154 |
| Issued Applications | 1970 |
| Pending Applications | 485 |
| Abandoned Applications | 741 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5291184
[patent_doc_number] => 20090023914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Process for preparing drospirenone and intermediate thereof'
[patent_app_type] => utility
[patent_app_number] => 12/151024
[patent_app_country] => US
[patent_app_date] => 2008-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5605
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023914.pdf
[firstpage_image] =>[orig_patent_app_number] => 12151024
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/151024 | Process for preparing drospirenone and intermediate thereof | Apr 30, 2008 | Abandoned |
Array
(
[id] => 4664441
[patent_doc_number] => 20080255348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'METHOD FOR THE PREPARATION OF AN ENANTIOMER OF A TETRACYCLIC BENZAZEPINE'
[patent_app_type] => utility
[patent_app_number] => 12/098662
[patent_app_country] => US
[patent_app_date] => 2008-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6238
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20080255348.pdf
[firstpage_image] =>[orig_patent_app_number] => 12098662
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/098662 | METHOD FOR THE PREPARATION OF AN ENANTIOMER OF A TETRACYCLIC BENZAZEPINE | Apr 6, 2008 | Abandoned |
Array
(
[id] => 4860352
[patent_doc_number] => 20080269202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents'
[patent_app_type] => utility
[patent_app_number] => 12/080418
[patent_app_country] => US
[patent_app_date] => 2008-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21078
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269202.pdf
[firstpage_image] =>[orig_patent_app_number] => 12080418
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/080418 | Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents | Apr 1, 2008 | Abandoned |
Array
(
[id] => 4728058
[patent_doc_number] => 20080207602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF ABETA PROTEIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/061227
[patent_app_country] => US
[patent_app_date] => 2008-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44104
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207602.pdf
[firstpage_image] =>[orig_patent_app_number] => 12061227
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/061227 | Succinoylamino benzodiazepines as inhibitors of aβ protein production | Apr 1, 2008 | Issued |
Array
(
[id] => 7685091
[patent_doc_number] => 20100121050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'PROCESSES FOR MAKING ZILPATEROL AND SALTS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/450253
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16948
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20100121050.pdf
[firstpage_image] =>[orig_patent_app_number] => 12450253
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/450253 | Processes for making zilpaterol and salts thereof | Mar 27, 2008 | Issued |
Array
(
[id] => 4683077
[patent_doc_number] => 20080249303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'METHODS OF SEPARATION AND DETECTION OF BAZEDOXIFENE ACETATE IN PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/057465
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10247
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249303.pdf
[firstpage_image] =>[orig_patent_app_number] => 12057465
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/057465 | METHODS OF SEPARATION AND DETECTION OF BAZEDOXIFENE ACETATE IN PHARMACEUTICAL COMPOSITIONS | Mar 27, 2008 | Abandoned |
Array
(
[id] => 4596100
[patent_doc_number] => 07981881
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'Fused heterocyclic compounds and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/050227
[patent_app_country] => US
[patent_app_date] => 2008-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31573
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/981/07981881.pdf
[firstpage_image] =>[orig_patent_app_number] => 12050227
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/050227 | Fused heterocyclic compounds and use thereof | Mar 17, 2008 | Issued |
Array
(
[id] => 4442401
[patent_doc_number] => 07928099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-19
[patent_title] => 'Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists'
[patent_app_type] => utility
[patent_app_number] => 12/532715
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52386
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/928/07928099.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532715
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532715 | Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists | Mar 13, 2008 | Issued |
Array
(
[id] => 6258502
[patent_doc_number] => 20100029934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'PROCESS FOR PRODUCTION OF MIRTAZAPINE'
[patent_app_type] => utility
[patent_app_number] => 12/443662
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3955
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029934.pdf
[firstpage_image] =>[orig_patent_app_number] => 12443662
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/443662 | Process for production of mirtazapine | Mar 12, 2008 | Issued |
Array
(
[id] => 4664181
[patent_doc_number] => 20080255088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'DIBENZO[b,f][1,4]OXAZAPINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/047858
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 26785
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20080255088.pdf
[firstpage_image] =>[orig_patent_app_number] => 12047858
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/047858 | Dibenzo[b,f][1,4]oxazapine compounds | Mar 12, 2008 | Issued |
Array
(
[id] => 4820282
[patent_doc_number] => 20080226593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Compounds for the Treatment of Hepatitis C'
[patent_app_type] => utility
[patent_app_number] => 12/046286
[patent_app_country] => US
[patent_app_date] => 2008-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17728
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226593.pdf
[firstpage_image] =>[orig_patent_app_number] => 12046286
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/046286 | Compounds for the treatment of hepatitis C | Mar 10, 2008 | Issued |
Array
(
[id] => 4820271
[patent_doc_number] => 20080226590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Compounds for the Treatment of Hepatitis C'
[patent_app_type] => utility
[patent_app_number] => 12/045766
[patent_app_country] => US
[patent_app_date] => 2008-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33736
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226590.pdf
[firstpage_image] =>[orig_patent_app_number] => 12045766
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/045766 | Compounds for the treatment of hepatitis C | Mar 10, 2008 | Issued |
Array
(
[id] => 4820275
[patent_doc_number] => 20080226592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Compounds for the Treatment of Hepatitis C'
[patent_app_type] => utility
[patent_app_number] => 12/046030
[patent_app_country] => US
[patent_app_date] => 2008-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21565
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226592.pdf
[firstpage_image] =>[orig_patent_app_number] => 12046030
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/046030 | Compounds for the treatment of Hepatitis C | Mar 10, 2008 | Issued |
Array
(
[id] => 4820274
[patent_doc_number] => 20080226591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Compounds for the Treatment of Hepatitis C'
[patent_app_type] => utility
[patent_app_number] => 12/045874
[patent_app_country] => US
[patent_app_date] => 2008-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37353
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226591.pdf
[firstpage_image] =>[orig_patent_app_number] => 12045874
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/045874 | Compounds for the treatment of hepatitis C | Mar 10, 2008 | Issued |
Array
(
[id] => 4808157
[patent_doc_number] => 20080171735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Abeta PROTEIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/045126
[patent_app_country] => US
[patent_app_date] => 2008-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44175
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12045126
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/045126 | SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Abeta PROTEIN PRODUCTION | Mar 9, 2008 | Abandoned |
Array
(
[id] => 8352075
[patent_doc_number] => 08247403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-21
[patent_title] => 'Benzoxazepine derivatives and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/449975
[patent_app_country] => US
[patent_app_date] => 2008-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 63164
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12449975
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/449975 | Benzoxazepine derivatives and use thereof | Mar 5, 2008 | Issued |
Array
(
[id] => 4698897
[patent_doc_number] => 20080221081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'POLYMORPHS OF 7-[(3-CHLORO-6,11-DIHYDRO-6-METHYLDIBENZO[C,F][1,2]THIAZEPIN-11-YL)AMINO]HEPTANOIC ACID S,S DIOXIDE AND METHODS OF MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/041747
[patent_app_country] => US
[patent_app_date] => 2008-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7691
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221081.pdf
[firstpage_image] =>[orig_patent_app_number] => 12041747
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/041747 | Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid S,S dioxide and methods of making and using the same | Mar 3, 2008 | Issued |
Array
(
[id] => 4619232
[patent_doc_number] => 07998951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-16
[patent_title] => 'HCV NS5B inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/041072
[patent_app_country] => US
[patent_app_date] => 2008-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15827
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/998/07998951.pdf
[firstpage_image] =>[orig_patent_app_number] => 12041072
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/041072 | HCV NS5B inhibitors | Mar 2, 2008 | Issued |
Array
(
[id] => 289076
[patent_doc_number] => 07547690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-16
[patent_title] => 'Compounds for the treatment of Hepatitis C'
[patent_app_type] => utility
[patent_app_number] => 12/039239
[patent_app_country] => US
[patent_app_date] => 2008-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50179
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/547/07547690.pdf
[firstpage_image] =>[orig_patent_app_number] => 12039239
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/039239 | Compounds for the treatment of Hepatitis C | Feb 27, 2008 | Issued |
Array
(
[id] => 4867485
[patent_doc_number] => 20080146544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'LISOFYLLINE ANALOGS AND METHODS FOR USE'
[patent_app_type] => utility
[patent_app_number] => 12/036646
[patent_app_country] => US
[patent_app_date] => 2008-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 9517
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20080146544.pdf
[firstpage_image] =>[orig_patent_app_number] => 12036646
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/036646 | Lisofylline analogs and methods for use | Feb 24, 2008 | Issued |